Relationship Between Basic Laboratory Results and Fibrosis in Chronic Hepatitis B Patients
Journal Title: Viral Hepatitis Journal - Year 2019, Vol 25, Issue 2
Abstract
Objectives: Liver biopsy (LB) is an important cornerstone in decision to start treatment for chronic hepatitis B (HB). Viral load and liver function tests are performed to determine the most appropriate time. In this study, factors affecting liver fibrosis in hepatitis B e antigen (HBeAg) negative chronic hepatitis B patients were investigated. Materials and Methods: LB and the other laboratory results such as alanine aminotransferase (ALT), aspartate aminotransferase (AST), gamma-glutamyl transpeptidase (GGT), and hepatitis B virus (HBV)-DNA were collected from patient files, retrospectively. According to study protocol, necroinflammatory scores ≤4 and fibrosis scores ≤1 were accepted as normal liver (NL), and the high value in one of these scores was accepted as chronic hepatitis (CH). Results: A total of 234 patient’s LBs included in the study. A total of 74 (31.6%) patients’ LB was evaluated as NL. In univariate analysis, age, gender, ALT, AST, GGT, AFP and HBV-DNA >100.000 IU/mL, and in multivariate analysis, age, AST level >29 U/L, and AFP level >2.5 ng/mL were the independent risk factors for CH. Conclusion: According to our results, age, AST and AFP predict CH. Doctors who follow up chronic hepatitis B patients should be carefully evaluate these parameters when giving LB decision.
Authors and Affiliations
Ertuğrul Güçlü, Aziz Öğütlü, Mustafa Kösem, Ünal Erkorkmaz, Oğuz Karabay
Keywords
Related Articles
- EP ID EP684554
- DOI 10.4274/vhd.galenos.2019.2019.0010
- Views 125
- Downloads 0
Hepatitis C Virus Genotype Distribution in Forensic Cases
Objectives: In this study, we aimed to determine the hepatitis C virus (HCV) genotype and subtypes in blood samples that were determined by polymerase chain reaction (PCR) in autopsy cases. Materials and Methods: The bl...
The Importance of Antiviral Prophylaxis against Hepatitis B Virus in Patients under Immunosuppressive Therapy
Objectives: Immunosuppressive (IS) therapies present a risk of reactivation in patients with previous or known hepatitis B virus (HBV) infection and may cause mortality and morbidity. Before starting these therapies, pat...
The Evaluation of the Relation Between Drug Compliance and Psychometric Tests in Chronic B Hepatitis Patients Who are Treated with Oral Antivirals
Objectives: Hepatitis B is a viral infection that causes acute and chronic hepatitis and serious complications such as cirrhosis and hepatocellular cancer. Several psychiatric symptoms and depression, particularly anxiet...
Effect of Hepatitis C Infection and Its Clearance on the Frequency of Coronary Artery Disease in Diabetics
Objectives: Chronic hepatitis C (CHC) infection considered to be associated with an increased risk of coronary artery disease (CAD). However, there is not enough data concerning this association in diabetics. Thus, this...
Investigating the Prevalence of Hepatitis Delta and Assessment of Treatment Response
Objectives: The purpose of this study was to investigate the seroprevalence of delta virus, assess the treatment outcomes of patients receiving treatment. Materials and Methods: The files of patients diagnosed with chro...